FRANKFURT (Reuters) – The world’s biggest central banks may be on the verge of securing the holy grail of monetary policy: an economic soft landing, despite the sharpest interest rate…
By Eric Onstad LONDON (Reuters) – Solid-state batteries hold the promise of more energy storage, longer driving ranges and faster charging for next-generation electric vehicles. Yet despite decades of research…
By Mike Scarcella (Reuters) – A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc’s challenge to a federal agency order requiring the biotechnology company to divest…
By Foo Yun Chee BRUSSELS (Reuters) -U.S. life sciences company Illumina is in talks with European Union antitrust regulators to divest Grail ahead of an expected EU veto next week…
(Reuters) – A judge has ruled in favor of Illumina Inc in its acquisition of Grail Inc dealing a blow to the U.S. Federal Trade Commission’s efforts to unwind the…
BRUSSELS – EU antitrust regulators are expected to veto U.S. life sciences firm Illumina’s acquisition of biotechnology company Grail, people familiar with the matter said on Wednesday. There are doubts…
By Foo Yun Chee LUXEMBOURG -U.S. life sciences company Illumina on Wednesday lost its challenge against European Union scrutiny of its $8 billion cash-and-stock takeover of Grail, as a top…
By Foo Yun Chee BRUSSELS – A European court will decide on July 13 whether U.S. life sciences company Illumina’s $8 billion cash-and-stock takeover of Grail should be scrutinised by…